Get started
Author

Ying Chang

A Bivalent Omicron-Containing Booster Vaccine against Covid-19
2022 · Spyros Chalkias, Charles Harper, et al. · New England Journal of Medicine · 616
PDF
Safety, immunogenicity and antibody persistence of a bivalent Beta-containing booster vaccine against COVID-19: a phase 2/3 trial
2022 · Spyros Chalkias, Frank Eder, et al. · Nature Medicine · 131
PDF
Immune response to SARS-CoV-2 after a booster of mRNA-1273: an open-label phase 2 trial
2022 · Laurence Chu, Keith Vrbicky, et al. · Nature Medicine · 102
PDF
Three-month antibody persistence of a bivalent Omicron-containing booster vaccine against COVID-19
2023 · Spyros Chalkias, Charles Harper, et al. · Nature Communications · 46
PDF
Safety and Immunogenicity of a 100 μg mRNA-1273 Vaccine Booster for Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)
2022 · Spyros Chalkias, Howard Schwartz, et al. · medRxiv · 13
PDF
Cytomegalovirus Proctitis Developed after COVID-19 Vaccine: A Case Report and Literature Review
2022 · Yuqing Lv, Ying Chang · Vaccines · 9
PDF
Impacts of the COVID-19 Pandemic on Health-Related Behaviours in Community Gardens in China: An Evaluation of a Natural Experiment
2024 · Siyu Chen, Ying Chang, et al. · Land · 7
LB750. Safety and Immunogenicity of a Bivalent Omicron-Containing Booster Vaccine against COVID-19
2022 · Spyros Chalkias, Charles Harper, et al. · Open Forum Infectious Diseases
AB040. Urbanisation, relocation and mental health of elderly farmers and the changes during the coronavirus disease (COVID-19) pandemic
2021 · Ying Chang, Guibo Sun, et al. · Journal of Public Health and Emergency
AB038. Neighbourhood health niche and well-being related behaviour change after coronavirus disease (COVID-19) pandemic
2021 · Siyu Chen, Ying Chang, et al. · Journal of Public Health and Emergency
Works count: 10
Citation count: 924
H-index: 7
I10-index: 5
Year
Topic
Type